Pfizer RSV vaccine wins CDC recommendation for seasonal use only
Pfizer’s shot to protect infants against respiratory syncytial virus by vaccinating their mothers won a limited recommendation.
Pfizer’s new shot to protect infants against respiratory syncytial virus by vaccinating their mothers late in pregnancy won a limited recommendation Friday from an expert panel that advises the Centers for Disease Control and Prevention, clearing the way for a second product to protect babies against RSV to soon hit the market.
The recommendation was accepted by CDC Director Mandy Cohen shortly after the conclusion of the panel’s meeting.
What's Your Reaction?
